Conducting CNS trials during a public health emergency – Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper

[1]  Philip D. Harvey,et al.  Feasibility and validity of ecological momentary cognitive testing among older adults with mild cognitive impairment , 2022, Frontiers in Digital Health.

[2]  Arun G. Chandrasekhar,et al.  End COVID-19 in low- and middle-income countries , 2022, Science.

[3]  S. Tong,et al.  Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19 , 2022, JAMA network open.

[4]  M. Tripathi,et al.  Suspend or amend? Randomized controlled trial on neuropsychological rehabilitation for epilepsy: A COVID-19 impact , 2021, Epilepsy & Behavior Reports.

[5]  B. Myers,et al.  Responding to COVID-19 threats to trial conduct: lessons learned from a feasibility trial of a psychological intervention for South African adolescents , 2021, Trials.

[6]  M. Anderson.  How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis , 2021, Bioanalysis.

[7]  M. Carrillo,et al.  Using Digital Tools to Advance Alzheimer’s Drug Trials During a Pandemic: The EU/US CTAD Task Force , 2021, The Journal of Prevention of Alzheimer's Disease.

[8]  David W. Johnson,et al.  Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response , 2021, Trials.

[9]  M. Fava,et al.  Conducting Clinical Research Remotely for Individuals with Traumatic Brain Injury (TBI) and Depression during the COVID-19 Pandemic: Transitioning from In-Person to Remote Implementation. , 2021, JMIR formative research.

[10]  Benjamin D. Smith,et al.  Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic , 2021, Advances in Radiation Oncology.

[11]  Jamie L. Adams,et al.  Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD) , 2020, Annals of clinical and translational neurology.

[12]  M. Mahoney,et al.  Transitioning to Remote Clinic Visits in a Smoking Cessation Trial During the COVID-19 Pandemic: Mixed Methods Evaluation , 2020, JMIR formative research.

[13]  Hiroyuki Tsutsui,et al.  Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) , 2020, European heart journal.

[14]  Norman Stockbridge,et al.  Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation. , 2019, Circulation.

[15]  J. Nikles,et al.  Barriers for conducting clinical trials in developing countries- a systematic review , 2018, International Journal for Equity in Health.